title: Who benefits from portal vein resection during pancreaticoduodenectomy for pancreatic cancer?
abstract: Portal vein resection during pancreaticoduodenectomy has recently experienced renewed interest. We describe our results with this procedure over a 20-year period. Among 88 consecutive pancreatectomies for cancer of head of the pancreas, 14 included en bloc removal of the portal vein. There was no hospital mortality. Only 21% were found to have histologically confirmed cancer invasion, and the remainder had inflammatory adherence. Two-year survival was 15% compared to 34% for patients who did not have portal vein resection. There were no 5-year survivors. We discuss our results in light of other recent reports.
authors.affiliation: Department of Digestive Surgery and Hepatobiliary Unit, Centre Medico Chirurgical Saint-Vincent, and University of Rennes, Avenue Saint Vincent, B.P. 129, Saint Gregoire 35760, France.
authors.forename: B
authors.initials: B
authors.lastname: Launois
authors.forename: C
authors.initials: C
authors.lastname: Stasik
authors.forename: E
authors.initials: E
authors.lastname: Bardaxoglou
authors.forename: B
authors.initials: B
authors.lastname: Meunier
authors.forename: J P
authors.initials: JP
authors.lastname: Campion
authors.forename: L
authors.initials: L
authors.lastname: Greco
authors.forename: F
authors.initials: F
authors.lastname: Sutherland
mesh_terms: D000230:Adenocarcinoma / Q000401:mortality / Q000601:surgery*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D010190:Pancreatic Neoplasms / Q000401:mortality / Q000601:surgery*; D016577:Pancreaticoduodenectomy; D011169:Portal Vein / Q000601:surgery*; D012189:Retrospective Studies; D016019:Survival Analysis; D016896:Treatment Outcome